Latest Updates
- COVID-19 Information on Paxlovid™ (PF-07321332 + ritonavir)
- Letter to prescribers regarding sacubitril and valsartan (Entresto) reimbursement
- MMP Preferred Product - Glatiramer acetate
- Letter to prescribers on removal of online application requirement for DOACs (October 2020)
- Anticoagulation Prescribing Tips (October 2020)
- Preferred Antibiotics Community (October 2020)
- MMP guidance for prescribers on HRT shortages (September 2020)
- Statin monotherapy for the treatment of hypercholesterolaemia and prevention of cardiovascular events in adults (July 2020)
- National Medicines Information Centre (NMIC) notification December 2019
- MMP Guidance for Prescribers on ranitidine shortage - October 2019
- Letter from Medicines Management Programme to prescribers and pharmacists in relation to the removal of the online application requirement for Apixaban (September 2019)
- Apixaban dosing information
- Proton pump inhibitors for the treatment of gastro-oesophageal reflux disease (July 2019)